期刊文献+

扁平苔藓皮损中STAT3、VEGF、CyclinD1的表达及其相关性研究 被引量:2

Expression and relationship of STAT3,VEGF and CyclinD1 in the lesions of lichen planus
下载PDF
导出
摘要 目的:探讨扁平苔藓皮损中细胞信号传导和转录激活因子(STAT3)、血管内皮生长因子(VEGF)、细胞周期素D1(CyclinD1)的表达及其意义。方法:采用免疫组化法检测23例扁平苔藓皮损中STAT3、VEGF、CyclinD1的表达,与12例正常皮肤、黏膜组织作对照,并分析其相关性。结果:STAT3、VEGF、CyclinD1在扁平苔藓皮损中阳性表达率分别为60.87%(14/23)、69.57%(16/23)和56.52%(13/23),在正常皮肤、黏膜组织中阳性表达率分别为8.33%(1/12)、16.67%(2/12)和8.33%(1/12),差异均有统计学意义(P<0.05)。扁平苔藓中STAT3与VEGF的表达,STAT3与CyclinD1的表达,VEGF与CyclinD1的表达均呈正相关(r=0.631,0.734,0.564;P=0.001,0.000,0.005)。结论:STAT3、VEGF、CyclinD1在扁平苔藓的发生、发展中可能起一定作用,三者之间可能相互协调。 AIM: To investigate the expres- sion of signal transducers and activators of tran- scription 3 ( STAT3 ), vascular endothelial growth factor(VEGF), CyclinD1 and their cor- relation in the lesions of lichen planus. METH- ODS: The expression levels of STAT3, VEGF and CyclinD1 in the 23 cases of lesions of lichen planus were detected by the immunohistochemis- try,and 12 cases of normal human tissues were also detected as control group. The expression and their relationship with pathological factors were analyzed. RESULTS. The expression rates of STAT3,VEGF and CyclinD1 in lichen planus were 60. 87% ( 14/23 ) 56.52% (13/23), the 69.57% ( 16/23 ) and expression ratesSTAT3, VEGF and CyclinD1 in the normal group were 8. 33% (1/12), 16.67% (2/12) and 8.33%(1/12). Compared with the control, the difference were significant (P〈0.05). Positive correlation between expression of STAT3 and VEGF, STAT3 and CyclinD1, VEGF and Cy- clinD1(r=0.631, 0.734, 0.564; P=0.001, 0. 000, 0. 005 ) were found. CONCLUSION: STAT3,VEGF and CyclinD1 may play a role in the development in the incidence of lichen pla- nus,coordination between them may play a role.
出处 《中国临床药理学与治疗学》 CAS CSCD 2013年第8期874-878,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 扁平苔藓 STAT3 VEGF CYCLIND1 表达 相关性 Lichen planus STAT3 VEGF CyclinD1 Expression Relationship
  • 相关文献

参考文献13

二级参考文献54

共引文献38

同被引文献22

  • 1张彩萍,崔盘根.银屑病微血管异常增生机制及治疗对策[J].国际皮肤性病学杂志,2006,32(1):23-25. 被引量:3
  • 2Claudio PP, Russo G, Kumar CA, et al. pRb2/p130, vascular endo- thelial growth factor, p27 (KIP1), and proliferating cell nuclear an- tigen expression in hepatocellular carrcinoma:Their clinical signifi- cance[J]. Clin Cancer Res,2004,10:3509 -3517.
  • 3Guset G, Costt S, Lazar E, et al. Expression of vascular endothelial growth factor(VEGF) and assessment of microvascular density with CD34 as prognstic markers for endometrial carcinoma [ J ]. Roma- nian J Morphol Embryol,2010,51 (4) :677 -682.
  • 4Fattaneh A, Tavassoil FA, Devilee P, et al. World Health Organiza- tion classification of tumours. Pathology and genetics of tumours of the breast and female genital organs [ M ]. Beijing : People's Health Publishing House ,2003:221 - 232.
  • 5Mattioli E, Vogiazi P, Sun A, et al. Immunohistochemical analysis of pRb2/p130 ,VEGF, EZH2, p53, p16 ( INK4A), p27 ( KIP1 ), p21 ( WAF1 ), Ki - 67 expression patterns in gastric cancer [ J ]. J Cell Physio1,2007,210( 1 ) :183 - 191.
  • 6Sanseverino F,Santopietro R,Torricelli G, et al. pRb2/pl30 and VEGF expression in endometrial carcinoma in relation to angiogen- esis and histopathologic tumor grade [ J ]. Cancer Biol Ther,2006,5 (1) :84 -88.
  • 7Koduri 5 Goldhar AS, Vonderhaar BK. Activation ol vascular en- dothelial growth factor(VEGF) by the ER -a variant, ERA3 [ J ]. Breast Cancer Res Treat,2006,95:37 - 43.
  • 8CREAMER K,ALEN M H,SOSRA A,et al.Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis[J].Br J Demratol,1997,136(6):859-865.
  • 9CREAMER D,ALLEN M,JAGGAR R,et al.Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor[J].Archives of Dermatology,2002,138(6):791-796.
  • 10XIA Yuping,LI Baosheng,HYLTON D,et al.Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis[J].Blood,2003,102(1):161-168.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部